Begin main content

ibrutinib

Last Updated: August 15, 2019
Result type: Reports
Product Line: Common Drug Review

Generic Name: ibrutinib

Brand Name: Imbruvica

Manufacturer: Janssen Canada Inc.

Indications: Chronic graft versus host disease

Submission Type: Non-submission

Project Status: Not filed

Recommendation Type: CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer